A comprehensive view of Vials. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.
Aptar Pharma to host June 6 webinar on derisking the development of sensitive injectables with PremiumCoat, its ETFE film-coated platform for vial stoppers and syringe plungers
Published:
April 03, 2024
by AptarGroup Inc.
|
Gerresheimer introduces three new performance levels for injection vials, syringes, cartridges and ampoules, the Gx Value, Gx Advance and Gx Elite; change expected to aid customers in choosing the appropriate products for their pharmaceutical requirements
Published:
April 03, 2024
by Gerresheimer AG
|
Eugia voluntarily recalls a batch of methocarbamol injection due to complaints of white particles inside a vial; recall involves lot number 3MC23011 in 1,000 milligram/10-milliliter single-dose vials distributed in January
Published:
April 02, 2024
by FiercePharma
|
Executive Perspective: Gerresheimer CEO predicts strong demand for weight-loss drugs to significantly boost the company's revenue growth; supply of vials, syringes, and other components for GLP-1 drugs expected to account for 4% of annual growth
Published:
April 01, 2024
by Invezz
|
Executive Perspective: Gerresheimer CEO predicts sales of vials, cartridges, syringes and autoinjectors related to GLP-1 medicines to surpass €100.0M this year, reach €350.0M within three years; greatest growth to come from 2025 to 2027
Published:
March 29, 2024
by Reuters
|
Ask us about our R&D/Patents market view